The new line of genetically modified mice with constitutive knockout of the gene alpha synuclein to study pathogenetic aspects of differential loss of dopaminergic neurons

  • Tatiana V. Tarasova Institute of Physiologically Active Compounds Russian Academy of Sciences (IPAC RAS), Chernogolovka, Moscow region, Russia; The Institute of general pathology and pathophysiology, Moscow, Russia
  • A. A. Ustyugov Institute of Physiologically Active Compounds Russian Academy of Sciences (IPAC RAS), Chernogolovka, Moscow region, Russia
  • N. N. Ninkina Institute of Physiologically Active Compounds Russian Academy of Sciences (IPAC RAS), Chernogolovka, Moscow region, Russia; The Institute of general pathology and pathophysiology, Moscow, Russia
  • V. I. Skvortsova Department of fundamental and clinical neurology and neurosurgery of Russian national research medical University Medicobiologic faculty, Moscow, Russia
Keywords: modulating effect of alpha-synuclein on the developing DA neurons in substantia nigra (SN) which is the most affected region in PD patients. Yet, alpha-synuclein had no effect on the formation of DA neurons in ventral tegmental area which is much less susceptible to degeneration in PD patients. Conclusion. The new line of knockout mice is a convenient model for studying pathophysiologic aspects of selective impairment of DA neurons

Abstract

The purpose. This study investigated the role of alpha-synuclein in the development of dopaminergic neurons. Methods. In this study a new SNCA knockout mouse line has been used to model the deficiency of alpha-synuclein function. In the knockout and control mice the dynamics of the formation of two distinct populations of dopaminergic neurons differently affected in patients with PD was studied by the comparative morphometric analysis. Results. Here, we revealed a

Downloads

Download data is not yet available.
Published
2016-08-07
How to Cite
Tarasova T. V., Ustyugov A. A., Ninkina N. N., Skvortsova V. I. The new line of genetically modified mice with constitutive knockout of the gene alpha synuclein to study pathogenetic aspects of differential loss of dopaminergic neurons // Patologicheskaya Fiziologiya i Eksperimental’naya Terapiya (Pathological physiology and experimental therapy). 2016. VOL. 60. № 3. PP. 4–9.
Section
Original research